My ePortfolio Register   
Management of Oral Chemotherapy in Older Patients

Management of Oral Chemotherapy in Older Patients

en English

Complete this module today and earn yourself 1 CME Point.

Proceed to module  Shortlist  Rate Module  Share
Language

en English

Summary This e-learning module has been developed in collaboration with the International Society of Geriatric Oncology (SIOG).
Description

The information in this module is based on the published 2015 European Journal of Cancer article ’Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology.

THIS E-LEARNING MODULE RUNS BEST ON MOZILLA FIREFOX AND INTERNET EXPLORER 7 AND ABOVE WITH FLASH ENABLED.

Target Audience

This module is for medical practitioners who wish to gain knowledge on the SIOG recommended guidelines for the management of prostate cancer in older patients.

Learning Objectives

By the end of this module, you should be able to:

  • Understand the challenges faced with managing older cancer patients.
  • Appreciate the advantages and disadvantages of using oral over intravenous chemotherapy.
  • Know the different available oral anticancer treatments for various cancer types and the risk for non-adherence.
IT Requirements

This module requires the learner to have a good, stable internet connection and runs best on INTERNET EXPLORER 7 AND ABOVE, and MOZILLA FIREFOX on either Windows or MacOS. FLASH ADD ON is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatability.

If you are experiencing technical difficulties, please contact info@ecancer.org and we will get back to you as soon as possible.

Commercial Support

Production of this module was funded by the International Society of Geriatric Oncology (SIOG) and by an unrestricted grant from Roche.

This e-learning module is valid for one year after publication and will expire...

Disclosure Policy

ecancer and Dr Laura Biganzoli, MD, Medical Oncology Department, New Prato Hospital, Istituto Toscano Tumori, Prato, Italy have no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this SIOG e-learning module which was made possible through an unrestricted educational grant from Roche.

 

Proceed to Module

Relevant to the following professions

  • Nurse
  • Oncologist
  • Other
  • Researcher
Proceed to module  Shortlist  Rate Module


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence